Union Health Ministry Moves Pregabalin to Schedule H1 — Tightening Prescription Controls

Overview The Ministry of Health and Family Welfare has issued Gazette Notification G.S.R. 377(E) on 13 May 2026 , published on 20 May 2026 , to bring Pregabalin under Schedule H1 . The move aims to curb misuse, especially among youth, and to tighten control over the drug’s supply chain. Key Developments Pregabalin will now be regulated under the stricter provisions of Schedule H1 instead of Schedule H. Sale is permitted only against a valid prescription issued by a Registered Medical Practitioner (RMP) . Retailers must keep a separate register of each prescription and sale. Manufacturers are required to display a prominent "Schedule H1 Drug Warning" label on the packaging. Any violation will attract penal action under the Drugs and Cosmetics Act, 1940 and its rules. Important Facts State reports indicated that Pregabalin was being abused for its sedative, euphoric and dissociative effects. Recent seizures of illegally stocked batches highlighted gaps in the existing Schedule H regime. By moving the drug to Schedule H1, the government adds a layer of prescription monitoring and supply‑chain accountability. The notification is available on the official e‑Gazette at https://egazette.gov.in/ (link provided in the release). UPSC Relevance This development touches upon several UPSC syllabus areas: Health Policy & Governance (GS1) : Shows how the government uses regulatory tools to address drug abuse. Legislative Framework (GS2) : Illustrates the role of the Drugs and Cosmetics Act, 1940 and the Drugs Rules, 1945 in public health regulation. Economic Implications (GS3) : Stricter control may affect the pharmaceutical market, pricing, and supply chain dynamics. Ethical Concerns (GS4) : Balances patient access to essential medicines with the need to prevent misuse. Way Forward All stakeholders—manufacturers, distributors, wholesalers, retailers, and pharmacists—must update their standard operating procedures to comply with the new schedule. Training programmes for pharmacists on prescription verification and record‑keeping are essential. Monitoring agencies should use the prescription registers to detect irregularities and take prompt action against violations. For UPSC aspirants, this case exemplifies how policy instruments are employed to address public‑health challenges, the importance of legal frameworks, and the need for inter‑departmental coordination.